Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer

BACKGROUND: Breast cancer is the most common malignancy in women, and neoadjuvant chemotherapy has been recommended to the patients with locally advanced breast cancer as the initial treatments. Long non-coding RNA (lncRNA) MEG3, an identified tumor suppressor, has been implicated in the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayarmaa, Battseren, Wu, Ziping, Peng, Jing, Wang, Yan, Xu, Shuguang, Yan, Tingting, Yin, Wenjin, Lu, Jinsong, Zhou, Liheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727505/
https://www.ncbi.nlm.nih.gov/pubmed/31488093
http://dx.doi.org/10.1186/s12885-019-6077-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727505/
https://www.ncbi.nlm.nih.gov/pubmed/31488093
http://dx.doi.org/10.1186/s12885-019-6077-3

Ejemplares similares